Parkinson's disease: presenting a gray box model

Shahriar Gharibzadeh et al. J Neuropsychiatry Clin Neurosci. 2009 Fall.

. 2009 Fall;21(4):470-1.

doi: 10.1176/jnp.2009.21.4.470.

No abstract available

Similar articles

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.
Braak H, de Vos RA, Bohl J, Del Tredici K. Braak H, et al. Neurosci Lett. 2006 Mar 20;396(1):67-72. doi: 10.1016/j.neulet.2005.11.012. Epub 2005 Dec 5. Neurosci Lett. 2006. PMID: 16330147
The metabolic landscape of Parkinson's disease.
Eidelberg D. Eidelberg D. Adv Neurol. 1999;80:87-97. Adv Neurol. 1999. PMID: 10410706 Review. No abstract available.
Basal ganglia oscillations and pathophysiology of movement disorders.
Rivlin-Etzion M, Marmor O, Heimer G, Raz A, Nini A, Bergman H. Rivlin-Etzion M, et al. Curr Opin Neurobiol. 2006 Dec;16(6):629-37. doi: 10.1016/j.conb.2006.10.002. Epub 2006 Nov 3. Curr Opin Neurobiol. 2006. PMID: 17084615 Review.
Anxiety disorders in Parkinson's disease: insights into the neurobiology of neurosis.
Schiffer RB. Schiffer RB. J Psychosom Res. 1999 Dec;47(6):505-8. doi: 10.1016/s0022-3999(99)00069-0. J Psychosom Res. 1999. PMID: 10661598 Review. No abstract available.
Nondopaminergic neurons in Parkinson's disease.
Hirsch EC, Orieux G, Muriel MP, Francois C, Feger J. Hirsch EC, et al. Adv Neurol. 2003;91:29-37. Adv Neurol. 2003. PMID: 12449099 Review. No abstract available.